日本の糖尿病市場は2020年から2024年にかけて力強い成長を遂げ、年平均成長率（CAGR）9.1%を達成しました。この上昇傾向は今後も続くと予想され、2025年から2029年にかけては年平均成長率（CAGR）7.1%で成長すると予測されています。2029年末までに、糖尿病市場は2024年の55億910万米ドルから約85億320万米ドルに拡大すると予測されています。
日本の糖尿病装置および治療薬市場は、CGMの普及拡大、デジタルヘルスの統合、治療薬デリバリーシステムの進歩、そして規制枠組みの進化によって進化しています。これらのトレンドは今後2〜4年でさらに加速し、患者モニタリングの改善、より正確な治療調整、そして市場全体の成長につながると予想されます。
日本の糖尿病装置および治療薬市場は、既存の多国籍企業と新興の国内企業がダイナミックに混在する市場です。近年の戦略的提携、合併、買収により競争環境は大きく変化しており、デジタル統合と規制対応がますます重視されています。今後数年間は、競争の激化と戦略的な統合により、日本全体でイノベーションが促進され、患者管理が強化されることが期待されます。
本レポートは、日本における糖尿病業界に関する詳細なデータ中心の分析を提供し、診断・モニタリング機器、治療薬、領域など、幅広い分野にわたる市場機会と分析を網羅しています。国レベルで50以上のKPIを網羅した本レポートは、糖尿病市場のダイナミクス、市場規模と予測、そして市場シェア統計に関する包括的な理解を提供します。
BioIntel360の調査手法は、業界のベストプラクティスに基づいています。独自の分析プラットフォームを活用した公平な分析により、新興ビジネスおよび投資市場の機会に関する詳細な見解を提供します。
本レポートは、2020年から2029年にかけての日本の糖尿病関連機器および治療薬市場について、データに基づいた詳細な分析を提供しています。主要な市場セグメントの概要は以下のとおりです。
目次
Table of Contents
1 Japan Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
2 Japan Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
2.1 Japan Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
2.2 Japan Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
3 Japan Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
4 Japan Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
5 Japan Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
6 Japan Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
7 Japan Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
8 Japan Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
9 Japan Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
10 Japan Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
11 Japan Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
12 Japan Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
13 Japan Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
14 Japan Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
List of Tables
Table 1: Japan Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Japan Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Japan Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Japan Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Japan Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Japan Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Japan Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Japan Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Japan Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Japan Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Japan Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Japan Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Japan Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Japan Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Japan Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Japan Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Japan Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Japan Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Japan Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Japan Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Japan Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Japan Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Japan Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Japan Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Japan Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Japan Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Japan Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Japan Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Japan Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Japan Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Japan Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Japan Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Japan Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Japan Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Japan Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Japan Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Japan Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Japan Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Japan Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Japan Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
Figure 1: Japan Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Japan Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Japan Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Japan Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Japan Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Japan Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Japan Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Japan Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Japan Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Japan Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Japan Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Japan Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Japan Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Japan Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Japan Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Japan Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Japan Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Japan Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Japan Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Japan Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Japan Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Japan Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Japan Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Japan Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Japan Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Japan Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Japan Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Japan Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Japan Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Japan Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Japan Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Japan Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Japan Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Japan Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Japan Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Japan Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Japan Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Japan Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Japan Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Japan Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Japan Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Japan Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Japan Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Japan Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Japan Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Japan Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Japan Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Japan Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Japan Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Japan Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Japan Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Japan Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Japan Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
